Analyst Recommendations

Bank of America Securities analyst issues BUY recommendation for RARE on March 12, 2026 03:55PM ET. The previous analyst recommendation was Buy.RARE was trading at $21.43 at issue...

March 12, 2026   RARE 2.31%

Leerink Partners analyst issues OUTPERFORM recommendation for TNYA on March 12, 2026 02:37PM ET. The previous analyst recommendation was Outperform.TNYA was trading at $0.907 at issue of the...

March 12, 2026   TNYA -1.47%

UBS analyst issues BUY recommendation for GRDN on March 12, 2026 11:11AM ET. The previous analyst recommendation was Buy.GRDN was trading at $33.835 at issue of the analyst...

March 12, 2026   GRDN 0.16%

BMO Capital analyst issues OUTPERFORM recommendation for CUZ on March 12, 2026 01:12PM ET. The previous analyst recommendation was Outperform.CUZ was trading at $22.965 at issue of the...

March 12, 2026   CUZ -1.22%

Bank of America Securities analyst issues UNDERPERFORM recommendation for CPB on March 12, 2026 01:12PM ET. The previous analyst recommendation was Underperform.CPB was trading at $22.7854 at issue...

March 12, 2026   CPB 0.49%

BMO Capital analyst issues MARKET PERFORM recommendation for DSGX on March 12, 2026 01:11PM ET. The previous analyst recommendation was Market Perform.DSGX was trading at $74.4653 at issue...

March 12, 2026   DSGX -0.95%

Cantor Fitzgerald analyst issues OVERWEIGHT recommendation for UTHR on March 12, 2026 01:11PM ET. The previous analyst recommendation was Overweight.UTHR was trading at $536 at issue of the...

March 12, 2026   UTHR -3.53%

Benchmark analyst issues BUY recommendation for TATT on March 12, 2026 12:34PM ET. The previous analyst recommendation was Buy.TATT was trading at $56.39 at issue of the analyst...

March 12, 2026   TATT 2.55%

Benchmark analyst issues BUY recommendation for EXOD on March 12, 2026 12:33PM ET. The previous analyst recommendation was Buy.EXOD was trading at $9.69 at issue of the analyst...

March 12, 2026   EXOD 1.85%

Piper Sandler analyst issues OVERWEIGHT recommendation for PLRX on March 12, 2026 01:20PM ET. The previous analyst recommendation was Overweight.PLRX was trading at $1.356 at issue of the...

March 12, 2026   PLRX 3.97%